CERA meaning in Medical ?

Answer:

What is Continuous Erythropoiesis Receptor Activator mean?

Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs.

Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA) in January 2008 to market a continuous erythropoiesis receptor activator (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia in patients with chronic kidney disease, including in those undergoing dialysis. . This issue appears to have been resolved since Fresenius Medical dialysis clinics in the US are now administering this drug.) Methoxy polyethylene glycol-epoetin beta had been approved by the European Commission in August 2007, and was made available in Europe at the start of 2008.

In terms of its structure, Mircera is similar to the previous synthetic EPO drugs, except that it is connected to a chemical called polyethylene glycol (PEG), which makes it last longer in the body. According to Roche, the product has the longest half-life of all FDA-approved erythropoiesis-stimulating agents (ESAs): up to 6 times longer than darbepoetin alfa and up to 20 times longer than epoetin. CERAs thus promise both lower dosing—significant owing to the high inherent cost of manufacturing recombinant protein drugs—and less frequent injections for patients. ESAs are administered via subcutaneous injections, often in doctor's offices for patients who lack the skill or dexterity to inject themselves, so the once- or twice-monthly dosing regimen for CERAs promises fewer costly, inconvenient office visits for patients requiring constant hemoglobin level maintenance for chronic kidney disease.

In clinical trials, CERA dosed every 3 to 4 weeks demonstrated efficacy similar to that of epoetin alfa and darbepoetin alfa in maintaining hemoglobin concentrations within the target hemoglobin range. CERA has generally been well tolerated in clinical trials.

reference

Full Form	Category
Conard Enviromental Research Area	Academic & Science
California Educational Research Association	Academic & Science
Converged Edge Reference Architecture	Academic & Science
Consumer Electronics Recycling Act	Academic & Science
Campus Ecological Research Area	Academic & Science
Concurrent Engineering Research Applications	Academic & Science
Canadian Educational Researchers Association	Business
Chartered Enterprise Risk Analyst	Business
Chartered Enterprise Risk Actuary	Business
Central Excise Revenue Audit	Business
Certified Enterprise Risk Actuary	Business
Central Electric Railfans' Association	Community
Community Education Resource Affiliation	Community
Communities Embracing Restorative Action	Community
Canadair Employees Recreation Association	Community
CAFM Educational Research Alliance	Community
Corporate Employee Recreation Association	Community
Concurrent Engineering Research and Applications	Computing
Cortical Evoked Response Audiometry	General
Continuous erythropoietin receptor activator	General
Centre for Equality Rights in Accommodation	General
Consortium for e Resources in Agriculture	General
Coastal Emergency Risks Assessment	General
Carolina Equine Rescue Assistance	General
Commute Expense Reimbursement Account	General
Chartered Entreprise Risk Analyst	General
Classic English Racing Automobiles	General
Campeonato de Espana de Rallyes de Asfalto	General
Comptoir d'Equipement et de Reparation Automobile	General
Center For Environmental Risk Assessment	Governmental
Conservation and Environmental Research Areas	Governmental
Canterbury Earthquake Recovery Authority	Governmental
Climate and Environmental Retrieval and Archive	Governmental
Cummins Employees Recreation Area	Governmental
Composite Explosive Reactive Armour	Governmental
Citizens Equal Rights Alliance	Governmental
Continuous Erythropoiesis Receptor Activator	Medical
capital expenditure from revenue account	Medical
Centre for Eye Research Australia	Medical
Cortical Electric Response Audiometry	Medical
Cambridge Energy Research Associates	Messaging
Cera Sanitaryware Limited	NSE Company Symbol
Centre for Eye Research Australia's	Regional
Central Railroad of Indianapolis	Regional
Central Railroad Company of Indianapolis	Regional
Connecticut Electric Railway Association	Regional